Should Lilly Stock Before April 10 Be on Your Radar?
As April 10 approaches, investors debate whether Lilly stock is a buy. This guide breaks down catalysts, valuation, a...
Pharmaceuticals
This tag page gathers 4 Pharmaceuticals articles covering stock moves, earnings previews, and dip-buys to help you evaluate pharma equities and manage risk.
13 articles
Drug Stocks March 2026: Top 3 Picks for Growth and Safety
In March 2026, the drug stock landscape blends steady demand with ongoing innovation. This article highlights three c...
Recall Affects 90,000 Bottles Children's Ibuprofen
Federal regulators are pulling nearly 90,000 bottles of children's ibuprofen from shelves after reports of foreign ma...
Should Avoid Pfizer? Here's the Key Risk to Watch Today
Pfizer has been a market mover, but recent shifts in demand and patent timelines raise concerns. This guide breaks do...
Pharmaceuticals Trio Draw Buy Ratings Ahead of 2026 Catalysts
A trio of small-cap biotechs—X4 Pharmaceuticals, Immuneering, and Tango Therapeutics—are attracting new and renewed a...
This Next-Gen Obesity Drug: Can It Save Novo Nordisk?
Novo Nordisk faces intense pressure in the fast-growing obesity treatment space. This article dives into whether this...
How to Amend Tax Return Online: Pharma Tariffs Impact
Pharmaceutical tariffs could quietly raise out-of-pocket drug costs and slow medical innovation. This guide explains ...
UroGen (URGN) 2025 Earnings: What Investors Should Know
As UroGen prepares to report 2025 results, investors weigh Jelmyto sales, pipeline progress, and balance-sheet health...
Here's Won't Touch Teva: Why I Pass on the Generic Giant
Teva Pharmaceuticals sits at a crossroads of debt, generics, and a shifting pricing landscape. Here's why I won't tou...
Down 25%, Should Bristol Be a Dip Buy Right Now Today?
When a blue-chip pharma stock falls 25%, many investors wonder if it's time to buy. This guide breaks down how to ass...
Bausch Health (BHC) 2025: Q4 Earnings Preview for Investors
As Bausch Health prepares its Q4 2025 results, investors want clarity on margins, debt, and the pipeline. This guide ...
One Reason Lilly Stock Never Sell: A Long-Term Investor’s Cornerstone
If you’re seeking a single, enduring reason to own Lilly stock, this article lays it out. You’ll learn how a durable ...